why choose us

First received: October 24, 2023

Clinical Trial: A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastroesophageal Reflux Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan (10 or 20 mg Once Daily) in Children Aged ? 6 to < 1

Brief Summary: The aim of this study is to evaluate the pharmacokinetic (PK) profile of vonoprazan (10 or 20 mg once daily [QD]) in children ? 6 to < 12 years of age who have symptomatic Gastroesophageal Reflux Disease (GERD).

Read more